fls.txt



item1.txt
Restricted stock units of 144,808 and 56,230, respectively, during the three and six months ended March 31, 2017 were excluded from the computation of diluted earnings per share based on the treasury stock method.
The escrow balance was $0.2 million as of March 31, 2018.
During the six months ended March 31, 2018, the net loss included non-recurring charges of $1.2 million related to the step-up in value of the acquired inventories.
 Acquisition of Pacific Bio-Material Management, Inc. and Novare, LLC
Please refer to Note 3, "Acquisitions" to the Company's consolidated financial statements included in the 2017 Annual Report on Form 10-K for further information on PBMMI acquisition.
The Company used a market participant approach to record the assets acquired and liabilities assumed in the Cool Lab acquisition.
During the three months ended March 31, 2018 and 2017, the Company recorded income of $1.4 million and $2.8 million, respectively, representing its proportionate share of UCIâ€™s earnings.
These arrangements guarantee the refund of advance payments received from our customers in the event that the product is not delivered or warranty obligations are not fulfilled in accordance with the contract terms.
 The Company evaluates the realizability of its deferred tax assets by tax-paying component and assesses the need for a valuation allowance on a quarterly basis, considering the weight of both positive and negative evidence in making the assessment.
UCI manufactures and sells cryogenic vacuum pumps, principally to ULVAC Corporation.
These arrangements guarantee the refund of advance payments received from our customers in the event that the product is not delivered or warranty obligations are not fulfilled in accordance with the contract terms.
 Performance-based awards granted in fiscal year 2016 also include provisions that allow participants to earn threshold, target and maximum awards ranging from 0% of the award for performance below the minimum threshold, 100% of the award for performance at target, and up to a maximum of 200% of the award if the Company achieves the maximum performance goals.
The Company paid to the sellers cash consideration of $34.3 million, net of cash acquired and subject to working capital adjustments.
The Company has established a project plan and substantially completed its preliminary contract assessment.
During the six months ended March 31, 2018, the Company capitalized direct costs of $0.3 million associated with development of software for its internal use.


item2.txt
 Cash Flows and Liquidity- Cash, cash equivalents and marketable securities were $245.2 million at March 31, 2018 as compared to $104.3 million at September 30, 2017.
Subject to certain conditions stated in the term loan agreement, we may redeem the term loan at any time at our option without a significant premium or penalty, except for a repricing transaction, as defined in the term loan agreement.
Additionally, the acquisitions of 4titude, PBMMI and FreezerPro, contributed incremental revenue of $12.9 million.
Operating income was $44.7 million during the six months ended March 31, 2018 as compared to $28.0 million for the corresponding period of the prior fiscal year.
performing this analysis.
These obligations could be called by the beneficiaries at any time before the expiration date of the particular letter of credit if we fail to meet certain contractual requirements.
 Item 2.
The increase in cash and cash equivalents and marketable securities of $140.9 million was primarily attributable to cash inflows related to proceeds from the term loan of $197.6 million and cash inflows of $23.4 million generated from our operating activities, partially offset by cash outflows related to acquisition payments of $65.0 million, dividend payments of $14.1 million made to our shareholders during the first half of fiscal year 2018, as well as capital expenditures of $5.7 million.
There were no such charges during the three months ended March 31, 2018.
from operating activities during the six months ended March 31, 2018 were comprised primarily of earnings of $57.6 million, including net income of $83.5 million and the impact of non-cash related charges of $25.9 million, partially offset by uses of cash of $34.2 million related to the changes in our operating assets and liabilities, net of acquisitions.
There were no amounts outstanding pursuant to the line of credit as of March 31, 2018 and September 30, 2017.
controls systems.
 Our unaudited consolidated financial statements are prepared in accordance with Generally Accepted Accounting Principles, or GAAP.


item3.txt
Most of these transactions or balances are denominated in Euros, British Pounds and a variety of Asian currencies.


item4.txt



part2.txt
There were no shares repurchased under this program during the six months ended March 31, 2018.


